These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 19527501
1. The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis. Shiraishi A, Miyabe S, Nakano T, Umakoshi Y, Ito M, Mihara M. BMC Musculoskelet Disord; 2009 Jun 15; 10():66. PubMed ID: 19527501 [Abstract] [Full Text] [Related]
5. Effect of risedronate on the cortical and cancellous bone mass and mechanical properties in ovariectomized rats: a comparison with the effects of alfacalcidol. Iwamoto J, Seki A, Takeda T, Sato Y, Yamada H, Yeh JK. J Nutr Sci Vitaminol (Tokyo); 2006 Dec 15; 52(6):393-401. PubMed ID: 17330501 [Abstract] [Full Text] [Related]
6. A comparison of alfacalcidol and menatetrenone for the treatment of bone loss in an ovariectomized rat model of osteoporosis. Shiraishi A, Higashi S, Masaki T, Saito M, Ito M, Ikeda S, Nakamura T. Calcif Tissue Int; 2002 Jul 15; 71(1):69-79. PubMed ID: 12073154 [Abstract] [Full Text] [Related]
9. Effects of combined treatment with eldecalcitol and alendronate on bone mass, mechanical properties, and bone histomorphometry in ovariectomized rats: a comparison with alfacalcidol and alendronate. Sugimoto M, Futaki N, Harada M, Kaku S. Bone; 2013 Jan 15; 52(1):181-8. PubMed ID: 23041510 [Abstract] [Full Text] [Related]
10. Lycopene treatment against loss of bone mass, microarchitecture and strength in relation to regulatory mechanisms in a postmenopausal osteoporosis model. Ardawi MM, Badawoud MH, Hassan SM, Rouzi AA, Ardawi JMS, AlNosani NM, Qari MH, Mousa SA. Bone; 2016 Feb 15; 83():127-140. PubMed ID: 26549245 [Abstract] [Full Text] [Related]
11. PTH has a more pronounced effect on vertebral bone mass and biomechanical competence than antiresorptive agents (estrogen and bisphosphonate)--assessed in sexually mature, ovariectomized rats. Mosekilde L, Søgaard CH, McOsker JE, Wronski TJ. Bone; 1994 Feb 15; 15(4):401-8. PubMed ID: 7917578 [Abstract] [Full Text] [Related]
13. Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2. Otomo H, Sakai A, Ikeda S, Tanaka S, Ito M, Phipps RJ, Nakamura T. J Bone Miner Metab; 2004 Feb 15; 22(5):404-14. PubMed ID: 15316861 [Abstract] [Full Text] [Related]
14. Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats. Li M, Mosekilde L, Søgaard CH, Thomsen JS, Wronski TJ. Bone; 1995 Jun 15; 16(6):629-35. PubMed ID: 7669439 [Abstract] [Full Text] [Related]
15. Topically administered Risedronate shows powerful anti-osteoporosis effect in ovariectomized mouse model. Nam SH, Jeong JH, Che X, Lim KE, Nam H, Park JS, Choi JY. Bone; 2012 Jan 15; 50(1):149-55. PubMed ID: 22036912 [Abstract] [Full Text] [Related]